CORVUS PHARMACEUTICALS INC

CRVSNASDAQ

🏆 #1815 by market capEarnings Nov 3US Equity

$14.73▲ $1.06 (+7.21%)

Live

1h—

24h▲ 7.2%

7d▲ 5.7%

14d▲ 13.0%

30d▲ 0.2%

1y▲ 226.6%

🏦Market Cap

$1.24B

Small Cap

📈Revenue Growth (YoY)

—

📊Gross Margin

—

💵FCF Margin

—

⚖️P/S Ratio

—

Otter Score

57

Weak

Earnings

Q3 · 2026Reported 2026-08-06

Earnings Per Share

Actual

-0.19

Expected

-0.16

miss

−19.40%

YoY −90.00%

Revenue

Actual

—

Expected

—

—

—

Consensus estimates

Recent quarters

Q3 2026

-0.19

miss

Q2 2026

-0.15

miss

Q1 2026

-0.15

miss

Q4 2025

-0.12

beat